COMP <GO>
NEUP vs ABBV // EV/EBITDA & P/E VALUATION
Neuphoria Therapeutics Inc. (NASDAQ) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: NEUP 0
— ABBV 9
■ METRIC PARITY
LAST: $3.06 (-8.93%) • MKT CAP: $16.6M
valuation
—
LAST: $290.79 (+1.68%) • MKT CAP: $513.86B
valuation
33.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NEUP VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NEUP | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 70.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -11.80% | 29.00% | -40.80 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 33.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.47% | 3.47% | -3.00 | ABBV | /fcf-yield <GO> |
| Operating Margin | -7.20% | 24.60% | -31.80 | ABBV | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 6.90% | -9.30 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | — | 8.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 5.33 | -5.13 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 25.4 | 65.1 | -39.67 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.15 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 113.1x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.6M | $513.86B | -$513.84B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NEUP REV | ABBV REV | NEUP GROSS % | ABBV GROSS % | NEUP FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $15.6M | $61.16B | — | 70.2% | $77.2K | $17.82B |
| FY 2024 | $0 | $56.33B | — | 70.0% | -$14.7M | $17.83B |
| FY 2023 | $0 | $54.32B | — | — | -$14.6M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NEUP // BETA —
ABBV // BETA 1.15